Results 141 to 150 of about 45,242 (261)

Overproduction and Characterization of Recombinant Soluble Trypanosoma brucei Phospholipase A2

open access: yesEngineering in Life Sciences
Trypanosoma brucei phospholipase A2 (TbPLA2) is a validated drug target but the difficulty in expressing its soluble recombinant protein has limited its exploitation for drug and vaccine development for African and American trypanosomiases.
Oluwafemi Abiodun Adepoju   +9 more
doaj   +1 more source

Apolipoprotein L1 (APOL1): Consideration of Molecular Evolution, Interaction with APOL3, and Impact of Splice Isoforms Advances Understanding of Cellular and Molecular Mechanisms of Cell Injury

open access: yesCells
The Apolipoprotein L1 (APOL1) innate immunity gene product represents the sole member of the APOL gene family in humans capable of secretion into circulation, thereby mediating the trypanolysis of T. brucei brucei.
Razi Khalaila, Karl Skorecki
doaj   +1 more source

Trypanosomiasis [PDF]

open access: yesPostgraduate Medical Journal, 1938
openaire   +2 more sources

A molecular mechanism for eflornithine resistance in African trypanosomes [PDF]

open access: yes, 2010
Human African trypanosomiasis, endemic to sub-Saharan Africa, is invariably fatal if untreated. Its causative agent is the protozoan parasite Trypanosoma brucei.
Creek, Darren   +7 more
core  

Oral fexinidazole for late-stage African Trypanosoma brucei gambiense trypanosomiasis: a pivotal multicentre, randomised, non-inferiority trial.

open access: yesThe Lancet, 2018
V. K. B. K. Mesu   +25 more
semanticscholar   +1 more source

Epidemiology of human African trypanosomiasis

open access: yes, 2014
Jose R Franco,1 Pere P Simarro,1 Abdoulaye Diarra,2 Jean G Jannin1 1World Health Organization, Control of Neglected Tropical Diseases, Innovative and Intensified Disease Management, Geneva, Switzerland; 2World Health Organization, Inter Country Support ...
Franco JR   +3 more
core  

Home - About - Disclaimer - Privacy